177 related articles for article (PubMed ID: 15552866)
1. [Treatment of spinal and bulbar muscular atrophy].
Adachi H; Katsuno M; Sobue G
No To Shinkei; 2004 Sep; 56(9):772-9. PubMed ID: 15552866
[No Abstract] [Full Text] [Related]
2. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy.
Banno H; Katsuno M; Suzuki K; Takeuchi Y; Kawashima M; Suga N; Takamori M; Ito M; Nakamura T; Matsuo K; Yamada S; Oki Y; Adachi H; Minamiyama M; Waza M; Atsuta N; Watanabe H; Fujimoto Y; Nakashima T; Tanaka F; Doyu M; Sobue G
Ann Neurol; 2009 Feb; 65(2):140-50. PubMed ID: 19259967
[TBL] [Abstract][Full Text] [Related]
3. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy.
Katsuno M; Adachi H; Doyu M; Minamiyama M; Sang C; Kobayashi Y; Inukai A; Sobue G
Nat Med; 2003 Jun; 9(6):768-73. PubMed ID: 12754502
[TBL] [Abstract][Full Text] [Related]
4. A case of spinal and bulbar muscular atrophy with high-stage and high-Gleason Score prostate cancer responded to maximal androgen blockade therapy.
Kosaka T; Miyajima A; Kikuchi E; Takahashi S; Suzuki N; Oya M
J Androl; 2012; 33(4):563-5. PubMed ID: 21940987
[TBL] [Abstract][Full Text] [Related]
5. [A mother and her son with autosomal dominant bulbar spinal muscular atrophy].
Ibi T; Suoh H; Igarashi S; Tsuji S; Sahashi K
Rinsho Shinkeigaku; 1992 Sep; 32(9):1038-40. PubMed ID: 1300263
[TBL] [Abstract][Full Text] [Related]
6. Anti-androgen treatment for spinal and bulbar muscular atrophy.
Fischbeck KH; Bryan WW
Ann Neurol; 2009 Feb; 65(2):119-20. PubMed ID: 19259961
[No Abstract] [Full Text] [Related]
7. Targeting toxic proteins for turnover.
La Spada AR; Weydt P
Nat Med; 2005 Oct; 11(10):1052-3. PubMed ID: 16211038
[No Abstract] [Full Text] [Related]
8. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy.
Thomas PS; Fraley GS; Damian V; Woodke LB; Zapata F; Sopher BL; Plymate SR; La Spada AR
Hum Mol Genet; 2006 Jul; 15(14):2225-38. PubMed ID: 16772330
[TBL] [Abstract][Full Text] [Related]
9. Nonneural nuclear inclusions of androgen receptor protein in spinal and bulbar muscular atrophy.
Li M; Nakagomi Y; Kobayashi Y; Merry DE; Tanaka F; Doyu M; Mitsuma T; Hashizume Y; Fischbeck KH; Sobue G
Am J Pathol; 1998 Sep; 153(3):695-701. PubMed ID: 9736019
[TBL] [Abstract][Full Text] [Related]
10. Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy.
Takeuchi Y; Katsuno M; Banno H; Suzuki K; Kawashima M; Atsuta N; Ito M; Watanabe H; Tanaka F; Sobue G
Muscle Nerve; 2008 Aug; 38(2):964-71. PubMed ID: 18642379
[TBL] [Abstract][Full Text] [Related]
11. Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker.
Banno H; Adachi H; Katsuno M; Suzuki K; Atsuta N; Watanabe H; Tanaka F; Doyu M; Sobue G
Ann Neurol; 2006 Mar; 59(3):520-6. PubMed ID: 16358333
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy.
Adachi H; Waza M; Katsuno M; Tanaka F; Doyu M; Sobue G
Neuropathol Appl Neurobiol; 2007 Apr; 33(2):135-51. PubMed ID: 17359355
[TBL] [Abstract][Full Text] [Related]
13. Neuropathology and therapeutic intervention in spinal and bulbar muscular atrophy.
Banno H; Katsuno M; Suzuki K; Tanaka F; Sobue G
Int J Mol Sci; 2009 Mar; 10(3):1000-12. PubMed ID: 19399234
[TBL] [Abstract][Full Text] [Related]
14. Pure bulbar motor neuron involvement linked to an abnormal CAG repeat expansion in the androgen receptor gene.
Praline J; Guennoc AM; Malinge MC; de Toffol B; Corcia P
Amyotroph Lateral Scler; 2008 Feb; 9(1):40-2. PubMed ID: 17852020
[TBL] [Abstract][Full Text] [Related]
15. 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration.
Waza M; Adachi H; Katsuno M; Minamiyama M; Sang C; Tanaka F; Inukai A; Doyu M; Sobue G
Nat Med; 2005 Oct; 11(10):1088-95. PubMed ID: 16155577
[TBL] [Abstract][Full Text] [Related]
16. [Clinical manifestations and molecular genetics of spinal bulbar muscular atrophy: report of 5 cases].
Li XH; Zhuang JJ; Xie QY; Li AP; Liang XL; Feng YQ; Fang YY; Li JR; Liang YX
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1611-5. PubMed ID: 17803850
[TBL] [Abstract][Full Text] [Related]
17. Alleviating neurodegeneration by an anticancer agent: an Hsp90 inhibitor (17-AAG).
Waza M; Adachi H; Katsuno M; Minamiyama M; Tanaka F; Sobue G
Ann N Y Acad Sci; 2006 Nov; 1086():21-34. PubMed ID: 17185503
[TBL] [Abstract][Full Text] [Related]
18. Hereditary motor neuronopathies.
Zamba-Papanicolaou E; Christodoulou K; Christodoulou C; Kyriakidesl T; Middleton LT
Rev Neurol (Paris); 2002 Dec; 158(12 Pt 1):1220-4. PubMed ID: 12690745
[No Abstract] [Full Text] [Related]
19. [Spinal and bulbar muscular atrophy (SBMA, Kennedy-Alter-Sung disease)].
Tanaka F; Sobue G
Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):375-8. PubMed ID: 10434677
[No Abstract] [Full Text] [Related]
20. Therapeutic approaches to spinal and bulbar muscular atrophy.
Ranganathan S; Fischbeck KH
Trends Pharmacol Sci; 2010 Nov; 31(11):523-7. PubMed ID: 20863580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
